Immune to Cancer: The CRI Blog
-
AACR18 Day 3 Update: Lung Cancer in the Spotlight, Immune Memory, and New Immunotherapy Biomarkers
Day 3 of AACR18 highlighted potentially “practice-changing” immunotherapy breakthroughs in lung cancer, and insights into the factors…
-
Checkpoint Immunotherapy Combination Approved for First-line Treatment of Advanced Kidney Cancer
The combination of checkpoint immunotherapies against PD-1 and CTLA-4 significantly improved survival and response rates compared to…
-
AACR18 Day 2 Update: What’s Next for Cancer Immunotherapy?
CRI scientists kicked off the opening plenary session at AACR18 and discussed several promising avenues of immunotherapy…
-
AACR18: Driving Innovative Cancer Science to Patient Care
This year’s annual AACR meeting boasts an impressive lineup of presentations highlighting both clinical and preclinical immunotherapy…
-
Healthcare Experts Tackle Tough Challenges at Fortune Brainstorm HEALTH 2018
CRI CEO highlights next steps in immunotherapy’s advancement at Fortune’s premier healthcare conference
-
Running for Hope at the 2018 UA New York City Half Marathon
Eighteen members of Team CRI ran the 13.1 mile 2018 United Airlines New York City Half Marathon…
-
Homesick Shows the Small Moments in Life with Cancer and Fundraises for Lifesaving Research
Behind-the-scenes of a new based-on-a-true-story comedy web series, “Homesick,” about an American living in London with a…
-
Durvalumab Becomes First Immunotherapy Approved for Stage III Lung Cancer
Immunotherapy tripled the median progression-free survival rate among lung cancer patients compared to those who received only…
-
Recap of the Fourth Annual Immuno-Oncology 360° Conference
The Fourth Annual Immuno-Oncology 360° Conference focused on comprehensive strategies for advancing immunotherapy, and was held from February…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.